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Abstract 
Purpose: Calcium, which is one the most abundant mineral elements in the body, has been suggested to 
be involved in blood pressure regulation. We aimed to assess the association of active serum calcium 
(iCa) (which is the ionized and physiologically active form of serum calcium) with the future risk of 
hypertension. 
Methods: Active serum calcium concentration was assessed at baseline in the Finnish Kuopio Ischemic 
Heart Disease population-based prospective cohort study of 1,562 normotensive men aged 42-61 years at 
baseline. Cox proportional hazard models were used to assess the hazard ratios (HRs) [95% confidence 
intervals (CIs)] for incident hypertension. 
Results: During a median follow-up of 24.9 years, 247 men developed new onset hypertension. Active 
serum calcium was inversely associated with incident hypertension in an approximately linear fashion. In 
age-adjusted analysis, the hazard ratio for hypertension per 1 standard deviation increase in iCa was 0.86 
(95% CI: 0.76-0.98), which remained consistent after adjustment for several established risk factors and 
potential confounders 0.82 (0.71-0.94). In a comparison of extreme quintiles of iCa levels, the 
corresponding adjusted hazard ratios were 0.59 (95% CI: 0.39 to 0.90) and 0.54 (95% CI: 0.35 to 0.82) 
respectively.  
Conclusion: Active serum calcium is protective of future hypertension in a middle-aged male Caucasian 
population. Further research is needed to confirm these findings and help unravel the mechanistic 
pathways of calcium in the pathogenesis of hypertension. 
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Introduction 
Calcium is one of the most abundant mineral elements in the body and only available to the body through 
dietary sources. It plays a major role in skeletal mineralization.1 Approximately 50% of total serum 
calcium is in ionized form,2 which is the physiologically active form of circulating calcium and a reliable 
indicator of calcium homeostasis.3 In healthy subjects, total serum calcium concentration ranges from 2.2 
to 2.6 mmol/l and the concentration of the ionized form is maintained within the range  1.10 to 1.35 
mmol/l.1 Increased serum levels of calcium have been demonstrated to be associated with the 
development of cardiovascular disease (CVD).4 Calcium may be involved in the regulation of blood 
pressure and emerging evidence suggests calcium could play a role in the pathophysiology of 
hypertension, which is an established risk factor for CVD and used in cardiovascular risk assessment.5 
However, there is sparse and inconsistent data on the nature of the association between serum calcium 
and hypertension and majority of studies reporting on the associations have been based on case-control 
and cross-sectional designs. Some studies have shown higher concentrations of calcium to be associated 
with increased risk of hypertension,6,7  whereas some have reported a protective effect,8,9  and others have 
reported null associations.10,11 In addition, these studies have relied on total or albumin-corrected 
estimates of serum calcium, which only approximate the levels of biologically active serum calcium 
(iCa).  
To date, there has not been any prospective evaluation of the association between iCa concentrations 
and risk of hypertension; therefore the temporal sequence of the relationship is still uncertain. In this 
context, we aimed to assess the prospective nature of the association between iCa concentrations and 
incident hypertension in a population-based cohort of 1,562 apparently healthy middle-aged men from 
eastern Finland.  
 
Methods 
Study population comprised a representative sample of men aged 42-61 years recruited into the Finnish 
Kuopio Ischemic Heart Disease (KIHD) risk factor study.12,13 The Research Ethics Committee of the 
University of Eastern Finland approved the study, and each participant gave written informed consent. 
Assessment of risk factors and confounders, ascertainment of incident hypertension, and details of 
statistical analyses have been reported previously14,15 and are described in the Supplementary Material. 
Briefly, the measurement of pH-corrected serum active calcium concentrations was made using ion 
selective electrodes (Microlyte 6, Kone, Finland; CV 1.6%). Incident hypertension was defined as a 
physician diagnosis of hypertension, SBP ≥ 140 mm Hg and/or DBP ≥ 90 mm Hg, or use of anti-
hypertensive medication. Incident cases were ascertained by record linkage to the national hospital 
discharge registry and to the Social Insurance Institution of Finland register for reimbursement of 
medicine expenses used for hypertension. Hazard ratios (HRs) with 95% confidence intervals (CIs) were 
calculated using Cox proportional hazard models.  All statistical analyses were conducted using Stata 
version 14 (Stata Corp, College Station, Texas). 
 
Results 
The mean age [standard deviation (SD)] of normotensive participants at baseline was 53 (5) years. The 
mean (SD) baseline iCa concentration was 1.18 (0.05) mmol/l. During a median follow-up of 24.7 
(interquartile range, 17.8-26.9) years, 247 new onset hypertension cases were recorded. In analysis 
adjusted for conventional risk factors (age, body mass index, systolic blood pressure, smoking status, 
history of diabetes, family history of hypertension, total cholesterol, high-density lipoprotein cholesterol, 
alcohol consumption, and physical activity), there was an approximately linear association between iCa 
concentrations and incident hypertension (Figure). The HR for hypertension per 1 SD increase in iCa was 
0.86 (95% CI: 0.76 to 0.98) in age-adjusted analysis, which remained consistent in further analyses 
adjusted for established risk factors 0.87 (95% CI: 0.76 to 0.99) and additional adjustment for renal 
function, socioeconomic status, total energy intake, and serum zinc 0.82 (95% CI: 0.71 to 0.94). 
Alternatively, comparing the top versus bottom quintiles of iCa levels, the corresponding adjusted HRs 
were 0.59 (95% CI: 0.39 to 0.90), 0.60 (95% CI: 0.39 to 0.92), and 0.54 (95% CI: 0.35 to 0.82) 
respectively (Table).  
 Discussion 
In this large-scale population-based prospective study of middle-aged Finnish men without a history of 
hypertension at baseline, baseline iCa concentration was approximately linearly and inversely associated 
with incident hypertension. The association was independent of several established risk factors for 
hypertension and other potential confounders.  
Evidence linking serum calcium and blood pressure have been limited and the results mostly 
inconsistent. A number of mechanistic pathways have been postulated linking increased serum 
concentrations of calcium with the development of high blood pressure and these include: (i) serum 
calcium has been suggested to have a direct effect on blood pressure by its effect on the contractility of 
the vascular smooth muscle cells which contributes to peripheral vascular resistance;16 (ii) alterations in 
intracellular calcium which determine the tension in vascular smooth muscle cells and also mediate the 
secretion of hormones such as catecholamines and angiotensin II, known to be involved in blood pressure 
control; (iii) calcium interacts with other ions such as magnesium, potassium, and sodium, which are 
involved in the regulation of blood pressure;17 (iv) vasoconstriction of the renal vasculature which 
eventually leads to hypertension;18 and (v) the effects of abnormal calcium levels on the blood pressure 
centers in the central nervous system.11  
Though our current findings do not seem to reflect on the biological pathways proposed, there is a 
possibility that the protective effect demonstrated may reflect a true association for the following reasons: 
(i) the actual mechanistic pathways linking calcium and blood pressure are uncertain and most of these 
proposed pathways are speculative; (ii) in contrast to our study which demonstrated this association using 
iCa (regarded as the gold standard of calcium measurement19), previous studies linking raised calcium 
levels with increased blood pressure have relied on total or albumin-corrected serum calcium 
measurements, which can bias the calcium-blood pressure relationship. In addition, previous reports 
reporting positive relationships were conducted in studies that employed limited designs. The large-scale 
prospective nature of our study conducted in apparently healthy normotensive free-living individuals; the 
high participation rate and no loss to follow-up; the long follow-up duration; and the detailed adjustment 
for a comprehensive panel of potential confounders, enhances the robustness of the results and minimises 
the likelihood of biases such as reverse causality and residual confounding, which were inherent in 
previous studies.; suggesting that there may be a true protective effect of iCa on the development of 
hypertension. Indeed, a number of observational and interventional studies have shown that calcium 
intake or supplementation is associated with blood pressure reduction.20,21 Given that calcium is only 
available to the body through dietary sources, this suggests that the amount of calcium from dietary 
sources or supplements will correlate with total serum calcium and iCa concentrations. Though the 
mechanisms underlying the protective association are also not clear, a number of pathways have been 
suggested. Low calcium intake leading to low serum calcium levels, stimulates increased levels of 
parathyroid hormone (PTH);1 which increases intracellular calcium concentrations leading to elevated 
blood pressure. Calcium also plays a role in the synthesis of prostaglandin, which has been demonstrated 
to influence the secretion of PTH.22 Finally, calcium has also been shown to have a beneficial effect on 
lipid levels in both animal models and humans.23,24 Our findings are relevant as they suggest that iCa 
might be protective of the risk of future hypertension. However, these results need to be interpreted with 
caution given limitations such as the relatively low event rate; lack of information on PTH and vitamin D; 
inability to correct for within-person variability in iCa levels due to absence of repeat measurements; and 
the lack of generalizability of the findings to other populations and age groups.  
In conclusion, iCa is inversely and independently associated with future risk of hypertension in an 
approximately linear fashion in a middle-aged Finnish male population. Further research is warranted to 
replicate these results and help unravel the biological pathways linking calcium and blood pressure 
regulation.  
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Figure legends 
 
Figure. Hazard ratios for incident hypertension, by quintiles of baseline levels of active serum calcium 
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A, adjusted for age; B, adjusted for age, body mass index, systolic blood pressure, smoking, history of 
diabetes, family history of hypertension, total cholesterol, high-density lipoprotein cholesterol, alcohol 
consumption, and physical activity 
iCa, active serum calcium 
  
Table. Association of Active Serum Calcium and Incident Hypertension 
Active serum calcium 
(mmol/l) 
Events/ 
Total 
Model 1  Model 2  Model 3  
  HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value 
Per 1 SD increase 247 / 1562 0.86 (0.76 to 0.98) 0.019 0.87 (0.76 to 0.99) 0.029 0.82 (0.71 to 0.94) 0.005 
Q1 (0.89-1.14) 63 / 318 ref  ref  ref  
Q2 (1.15-1.17) 59 / 375 0.78 (0.55 to 1.12) 0.182 0.80 (0.56 to 1.15) 0.224 0.78 (0.54 to 1.12) 0.174 
Q3 (1.18-1.19) 37 / 264 0.65 (0.44 to 0.98) 0.041 0.67 (0.45 to 1.01) 0.059 0.61 (0.40 to 0.92) 0.019 
Q4 (1.20-1.22) 53 / 351 0.70 (0.48 to 1.01) 0.058 0.74 (0.51 to 1.07) 0.110 0.66 (0.45 to 0.96) 0.031 
Q5 (1.23-1.45) 35 / 254 0.59 (0.39 to 0.90) 0.014 0.60 (0.39 to 0.92) 0.019 0.54 (0.35 to 0.82) 0.005 
 
CI, confidence interval; HR, hazard ratio; ref, reference; Q, quartile; SD, standard deviation 
Model 1: Adjusted for age  
Model 2: Model 1 plus body mass index, systolic blood pressure, smoking, history of diabetes, family history of hypertension, 
total cholesterol, high-density lipoprotein cholesterol, alcohol consumption, and physical activity 
Model 3: Model 2 plus estimated glomerular filtration rate, socioeconomic status, total energy intake, and serum zinc 
 
 
 
 
 
 
 
 
 
